Dr. Martens (LON:DOCS) Hits New 12-Month Low – Should You Sell?

Dr. Martens plc (LON:DOCSGet Free Report) shares hit a new 52-week low during trading on Thursday . The company traded as low as GBX 47.52 ($0.62) and last traded at GBX 49.56 ($0.64), with a volume of 3938522 shares. The stock had previously closed at GBX 53 ($0.69).

Dr. Martens Stock Down 6.5 %

The company has a market capitalization of £481.11 million, a price-to-earnings ratio of 7.03, a P/E/G ratio of 6.40 and a beta of 0.11. The business has a fifty day simple moving average of GBX 63.45 and a two-hundred day simple moving average of GBX 63.17. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.

Dr. Martens Cuts Dividend

The business also recently declared a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, March 6th. Dr. Martens’s dividend payout ratio is 42.53%.

Insider Buying and Selling at Dr. Martens

In other news, insider Giles Wilson acquired 32,640 shares of the firm’s stock in a transaction on Tuesday, March 25th. The shares were purchased at an average cost of GBX 54 ($0.70) per share, with a total value of £17,625.60 ($22,887.42). Insiders have purchased 33,338 shares of company stock worth $1,807,831 over the last three months. Company insiders own 4.36% of the company’s stock.

About Dr. Martens

(Get Free Report)

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.

Read More

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.